Diligence memo · auto-generated · as of July 2, 2026
Kaida BioPharma Inc.
Kaida BioPharma Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Kaida BioPharma Inc. operates in Biotechnology, based in FORT LAUDERDALE.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Kaida BioPharma Inc. has raised $1.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.6M on 2023-10-24.
Most recent recorded round closed around 2023-10-24.
Valuation (modeled)modeled
Provath models Kaida BioPharma Inc. at approximately $11M (range $1.1M–$36M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.78× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era. Within the normal band (78% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2.7 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 24% of Biotechnology peers (4293 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.